LCE1B

 

Full name: late cornified envelope 1B Alias Symbol: LEP2
Type: protein-coding gene Cytoband: 1q21.3
Entrez ID: 353132 HGNC ID: HGNC:16611 Ensembl Gene: ENSG00000196734 OMIM ID: 612604
Drug and gene relationship at DGIdb

 

Expression of LCE1B:

 

Dataset Gene EntrezID Probe Log2FC Adj.pValue Expression
GSE17351 LCE1B 353132 1560531_at 0.2390 0.4574
GSE26886 LCE1B 353132 1560531_at -0.0773 0.5952
GSE45670 LCE1B 353132 1560531_at 0.2477 0.1620
GSE53622 LCE1B 353132 476 0.6343 0.0000
GSE53624 LCE1B 353132 476 0.1175 0.5401
GSE63941 LCE1B 353132 1560531_at -0.0409 0.7549
GSE77861 LCE1B 353132 1560531_at -0.0393 0.7715
GSE97050 LCE1B 353132 A_33_P3356816 -0.2155 0.5442
TCGA LCE1B 353132 RNAseq 3.4631 0.0002

Upregulated datasets: 1; Downregulated datasets: 0.  


 

Survival by LCE1B expression:

 

GSE53622GSE53624TCGA

 

Note: Click image to view full size file.  


Copy number change of LCE1B:

 

Dataset Gene EntrezID Gain Loss Normal Detail
GSE15526 LCE1B 353132 15 0 15
GSE20123 LCE1B 353132 15 0 15
GSE43470 LCE1B 353132 6 2 35
GSE46452 LCE1B 353132 3 1 55
GSE47630 LCE1B 353132 15 0 25
GSE54993 LCE1B 353132 0 4 66
GSE54994 LCE1B 353132 15 0 38
GSE60625 LCE1B 353132 0 0 11
GSE74703 LCE1B 353132 6 1 29
GSE74704 LCE1B 353132 7 0 13
TCGA LCE1B 353132 39 2 55

Total number of gains: 121; Total number of losses: 10; Total Number of normals: 357.  


 

Somatic mutations of LCE1B:

 

Generating mutation plots.

 

Highly correlated genes for LCE1B:

 

Showing top 20/21 corelated genes with mean PCC>0.5.
Gene1 Gene2 Mean PCC Num. Datasets Num. PCC<0 Num. PCC>0.5
LCE1BLINC010130.644298303
LCE1BFBXL80.62075303
LCE1BCACNA1G0.619027303
LCE1BIL9R0.618267303
LCE1BC14orf1800.616041303
LCE1BC1QTNF60.605026403
LCE1BHS2ST10.58913303
LCE1BKRT250.586374303
LCE1BLCE2B0.580717403
LCE1BLCE6A0.566306403
LCE1BLCE2A0.563911303
LCE1BPAX20.561645403
LCE1BGHRHR0.555001404
LCE1BLCE2D0.548855403
LCE1BSMOC10.548778303
LCE1BKIR2DL40.547759403
LCE1BSLC5A40.546203403
LCE1BMED190.531852303
LCE1BSLC5A110.531448403
LCE1BTEX13B0.518476503

For details and further investigation, click here